Wilbanks Smith & Thomas Asset Management LLC Citius Pharmaceuticals, Inc. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$1.38 - $1.89 $67,723 - $92,751	-49,075 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$1.74 - $2.6 $3,149 - $4,706	1,810 Added 3.83%	49,075 $100,000
Q2 2021 Aug 04, 2021	BUY	$1.51 - $4.23 $41,170 - $115,330	27,265 Added 136.33%	47,265 $164,000
Q3 2020 Nov 12, 2020	BUY	$0.83 - $1.51 $16,600 - $30,200	20,000 New	20,000 $21,000

Others Institutions Holding CTXR

# of Institutions

Shares Held

23.7M

Call Options Held

83.1K

Put Options Held

32.1K

Armistice Capital, LLC New York, NY

7.28M
Shares

$18.7 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

6.44M
Shares

$16.6 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.88M
Shares

$4.83 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.81M
Shares

$4.64 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.16M
Shares

$2.98 Million
0.0% of portfolio

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $376M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account